ADC Therapeutics SA (ADCT) earnings · rev $81.4M
These earnings events as JSON? API free 100/dayADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
This ADCT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ADCT revenue for 2025-12-31 was $81.4M. Net income was -$142.6M. Revenue was up 14.9% from 2024-12-31 to 2025-12-31. ADCT currently screens at market cap $141.2M.
When the next ADCT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 14.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ADCT research stays on the stock page; the tape stays on the quote page.
ADCT earnings FAQ
What are ADCT's latest revenue and net income?
Latest cached ADC Therapeutics SA (ADCT) revenue for Dec 31, 2025 was $81.4M. Net income was -$142.6M. Statements: https://lician.com/financials/adct
What is ADCT's latest diluted EPS?
Latest cached ADC Therapeutics SA (ADCT) diluted EPS for Dec 31, 2025 was -$1.12.
What period does the latest ADCT earnings print cover?
The latest cached ADC Therapeutics SA (ADCT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ADCT revenue change from the prior cached period?
Cached ADC Therapeutics SA (ADCT) revenue was up 14.9% from $70.8M (Dec 31, 2024) to $81.4M (Dec 31, 2025). Statements: https://lician.com/financials/adct
Where are ADCT earnings listed?
Cached earnings facts for ADC Therapeutics SA (ADCT) are listed at https://lician.com/earnings/adct. Statements: https://lician.com/financials/adct
Not investment advice.